# Rallybio Sets 1-for-2 Reverse Split Ahead of Avenzo Merger

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54459
Published: 2026-11-11T21:00:00.000Z
Updated: 2026-11-11T21:00:00.000Z
Section: Business

> The split is scheduled to take effect at 4:01 p.m. ET on Nov. 20, with split-adjusted trading expected to begin Nov. 23.

Rallybio Corporation has approved a 1-for-2 reverse stock split ahead of its anticipated merger with Avenzo Therapeutics, Inc., with the change scheduled to take effect Nov. 20.

The split is set for 4:01 p.m. ET (21:01 UTC). Under the 1-for-2 ratio, every two existing shares will be consolidated into one share. Split-adjusted trading is expected to begin Nov. 23.